Overview Phase III Clinical Trial of DA-5212 in Patients With Functional Dyspepsia Status: Not yet recruiting Trial end date: 2024-12-01 Target enrollment: Participant gender: Summary This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia Phase: Phase 3 Details Lead Sponsor: Dong-A ST Co., Ltd.